Credit Suisse Starts Sucampo Pharmaceuticals (SCMP) at Neutral

Credit Suisse initiates coverage on Sucampo Pharmaceuticals (NASDAQ: SCMP) with a Neutral. PT $8.00.

For an analyst ratings summary and ratings history on Sucampo Pharmaceuticals click here. For more ratings news on Sucampo Pharmaceuticals click here. Shares of Sucampo Pharmaceuticals closed at $6.47 yesterday, with a 52 week range of $3.78-$10.18.

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks